Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABVC BioPharmaABVC +15.67%21 3-Year FCF Growth Rate is 60.40% as of Jun. 2026, which is 239% above its 10-year median of 17.80. GuruFocus rates ABVC with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 1,108 Biotechnology companies, ABVC BioPharma ranks better than 90.16% on this metric.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 60.40% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 49.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of ABVC BioPharma was 67.00% per year. The lowest was -79.00% per year. And the median was 17.80% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
ABVC BioPharma 3-Year FCF Growth Rate Related Terms
ABVC vs ALLR, MRKR, CNSY: 3-Year FCF Growth Rate Comparison
For the Biotechnology subindustry, ABVC BioPharma's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABVC BioPharma 3-Year FCF Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ABVC BioPharma's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where ABVC BioPharma's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 60.40% mean?
ABVC BioPharma (ABVC) has a 3-Year FCF Growth Rate of 60.40% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for ABVC BioPharma and its competitors. This is 239% above median its historical median of 17.80. According to the industry distribution chart, ABVC BioPharma ranks #109 out of 1108 companies in the Biotechnology industry, placing it in the top 9.8%.
Is ABVC BioPharma's 3-Year FCF Growth Rate too high?
ABVC BioPharma's current 3-Year FCF Growth Rate of 60.40% is 239% above median its 10-year median of 17.80. The Biotechnology industry median 3-Year FCF Growth Rate is 19.30. ABVC BioPharma's value of 60.40% is 213% above this industry median. Based on the distribution chart, ABVC BioPharma ranks #109 out of 1108 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, ABVC BioPharma has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does ABVC BioPharma's 3-Year FCF Growth Rate compare to ALLR and MRKR?
According to the Biotechnology industry distribution chart, ABVC BioPharma ranks #109 out of 1108 companies for 3-Year FCF Growth Rate. This places ABVC BioPharma in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year FCF Growth Rate is 19.30. ABVC BioPharma's value of 60.40% is 213% above this benchmark. While the company's 10-year median is 17.80 vs. the industry median of 19.30, ABVC BioPharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Biotechnology company?
The median 3-Year FCF Growth Rate among Biotechnology companies is 19.30, based on 1,108 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABVC BioPharma's current 3-Year FCF Growth Rate of 60.40% is 213% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for ABVC BioPharma and its competitors. For the Biotechnology industry, the median 3-Year FCF Growth Rate is 19.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABVC BioPharma's current 3-Year FCF Growth Rate is 60.40%, which is 239% above median its own 10-year median of 17.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABVC BioPharma stock overvalued right now?
ABVC BioPharma (ABVC) has a current 3-Year FCF Growth Rate of 60.40%. The current 3-Year FCF Growth Rate is 60.40%, which is 239% above median its 10-year median of 17.80 and 213% above the Biotechnology industry median of 19.30. ABVC BioPharma's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For ABVC BioPharma (ABVC), the current 3-Year FCF Growth Rate is 60.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
21GF Score
Get the complete analysis for ABVC
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABVC has been successfully added to your 
